In spite of remaining manufactured for less than $five per month, copyright carries a retail rate that is challenging to justify. The significant hole among production expenditures and pricing raises vital questions about the pharmaceutical marketplace's pricing techniques.In October 2024, Novo Nordisk printed a study on scientific journal Nature a